Klenprime 40

Klenprime 40


Manufacturer: Eminence Labs
Substance: Clenbuterol
Package: 40 mcg / tab. (50 tab.)


General information on Clenbuterol 0.04 mg in Italy

Clenbuterol is manufactured by So Pharma. It contains 50 Celenbuterol tablets which are not included as a steroid but is widely used by bodybuilders and athletes. In fact, it was developed for the treatment of chronic respiratory diseases such as asthma. In doing this, due to (generates heat) has its thermogenic effects, it promotes the burning of fat in the body. At this point, it is a suitable choice for people in the field of bodybuilding. Clenbuterol increased the metabolism rate; It also helps to use stored fat in the process of carbonhydrates and converting fat into usable energy. It possesses its reputation for stimulating muscle mass and breaking down stored fat in the body.

Characteristics Clenbuterol 0.04 mg in Italy

The side effects of Clenbuterol are dose dependent. The main ones include headaches, nervousness, insomnia, sweating, hypertension, increased appetite, and muscle cramps. Muscle spasm is one of the most serious side effects of Clenbuterol. This is probably due to the reduction of amino acid taurine in the liver. It is recommended for those who face muscle cramps after using Clenbuterol; eat fruit, especially bananas; in order to take taurine supplementation and take potassium supplementation. it should also be noted that induviduals who have high blood pressure (hypertension) have a need to avoid stimulants such as clenbuterol.

The effects of taking Clenbuterol 0.04 mg in Italy

Clenbuterol results in its use in a direct down-regulation of beta-2-receptors thanks to its powerful stimulating effects. This is why it is useless to use Clenbuterol for long periods without a break. According to most bodybuilders, a two-day and two-day rest dosing schedule offers pretty decent potential for receptor up-regulation.


There are no reviews yet.

Be the first to review “Klenprime 40”

Your email address will not be published. Required fields are marked *